FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint - Drugs.com MedNews
Links shared publicly online about this topic.
- 49total visits
FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint - Drugs.com MedNews
Conference Call to be Held at 9 00 a.m. Eastern Time on August 24, 2011 United Therapeutics Corporation (NASDAQ UTHR) announced today the completion of its FREE
View full resource at drugs.com
Tags: Heart Disease, High Blood Pressure, Drug, Pulmonology
Most Recently Shared on August 24, 2011 at 2:10 pm By:
FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint:... http://t.co/w6H23Ib #drug
Advertisement
